can tirzepatide increase heart rate Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Does the drug cause your

Do you treat patients with conditions like diabetes or PCOS

It is important to motivate people to keep transparent communication with their medical service specialists by promptly notifying them of any problems or worries they may have

it can be immediately life-threatening

Additional SURMOUNT Trials Cardiovascular Outcomes Trials SURPASS-CVOT (NCT04255433) Study Title: "Cardiovascular Outcomes Following Tirzepatide Treatment in Participants With Type 2 Diabetes and Increased Cardiovascular Risk" Status: Ongoing Phase: Phase 3 Enrollment: ~12,500 participants Study Period: 2020-2025 (estimated) Design: Randomized, double-blind, placebo-controlled event-driven trial Duration: Event-driven (minimum 3 years) Intervention: Tirzepatide up to 15 mg vs